Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | -3.00% | +4.86% | +41.61% |
Financials (USD)
Sales 2022 | 2.38M | Sales 2023 | - | Capitalization | 10.25M |
---|---|---|---|---|---|
Net income 2022 | -50M | Net income 2023 | -65M | EV / Sales 2022 | 21.8 x |
Net cash position 2022 | 5.73M | Net Debt 2023 | 13.17M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.14
x | P/E ratio 2023 |
-0.11
x | Employees | 26 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.82% |
Latest transcript on iBio, Inc.
1 day | -3.00% | ||
1 week | +4.86% | ||
Current month | +13.45% | ||
1 month | -14.16% | ||
3 months | +69.43% | ||
6 months | -65.96% | ||
Current year | +41.61% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Brenner
CEO | Chief Executive Officer | 54 | 21-01-17 |
Felipe Duran
DFI | Director of Finance/CFO | 45 | 21-03-31 |
Phan Dillon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chip Clark
CHM | Chairman | 56 | 21-08-22 |
Linda Armstrong
BRD | Director/Board Member | 61 | 20-10-13 |
Gary Sender
BRD | Director/Board Member | 62 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1.94 | -3.00% | 31 742 |
24-05-07 | 2 | +0.50% | 41,397 |
24-05-06 | 1.99 | 0.00% | 68,485 |
24-05-03 | 1.99 | -1.97% | 174,341 |
24-05-02 | 2.03 | +9.73% | 618,383 |
Delayed Quote Nyse, May 08, 2024 at 12:01 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+41.61% | 17.22M | |
+32.87% | 700B | |
-4.86% | 358B | |
+18.99% | 330B | |
+3.28% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+5.12% | 161B | |
-2.05% | 157B |
- Stock Market
- Equities
- IBIO Stock